Proscia, a leading pathology AI company, has successfully completed its SOC 2 Type II audit, marking a significant achievement in enterprise security and operational reliability. This accomplishment highlights Proscia’s commitment to providing a secure and dependable platform for large-scale digital pathology, making it a trusted partner for life sciences organizations and diagnostic laboratories. In 2025, Proscia reached a record number of enterprise go-lives, demonstrating its growing adoption across the industry.
Health Technology Insights: TurnOnGreen to Power New High-Precision Medical Laser
SOC 2 Type II certification is recognized by the American Institute of Certified Public Accountants as a benchmark for evaluating an organization’s controls over security, availability, and confidentiality. By earning this certification, Proscia demonstrates that its security measures are not only robust but also consistently effective over time. This recognition complements Proscia’s existing security and compliance standards, including ISO 27001 certification for information security and ISO 13485 compliance for medical device quality management, reinforcing the company’s leadership in secure digital pathology solutions.
Coleman Stavish, Chief Technology Officer at Proscia, emphasized the importance of security, stating that protecting sensitive patient data is a core principle of the company. He noted that leading pharmaceutical companies and diagnostic laboratories depend on Proscia’s platform for critical workflows, and the SOC 2 Type II certification reflects the company’s strong security culture and operational discipline.
Health Technology Insights: Lipocine Reports Positive Phase 3 Safety for LPCN 1154
Proscia’s Concentriq AI platform supports a wide range of pathology workflows, from drug development to clinical diagnostics. Its user base includes sixteen of the top twenty pharmaceutical companies and major laboratories that rely on the platform to complete over eight million diagnoses annually.
The company’s certified security framework enhances its ability to scale enterprise deployments. Proscia has successfully implemented Concentriq across hundreds of sites in the past year, supported by seamless interoperability with laboratory information systems such as Epic Beaker, CoPath, NovoPath, LigoLab, and Orchard Harvest. The platform integrates more than 125 AI applications, allowing precision medicine tools to work directly within Concentriq. Hosted on Amazon Web Services, the platform provides secure cloud storage, scalable performance, and integration with AWS HealthImaging for managing whole slide images at petabyte scale. Proscia also offers continuous expert support to ensure laboratories maintain operational efficiency and meet critical diagnostic turnaround times.
With SOC 2 Type II certification and a proven record of enterprise-scale deployments, Proscia reinforces its position as a secure, reliable, and innovative partner for organizations advancing digital pathology and precision medicine.
Health Technology Insights: InteliChart Launches InteliSense to Power a New Era of Patient Engagement
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
